These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2109590)

  • 41. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
    Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
    J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting T cell killing with complement component C3-anti CD3 fusion proteins.
    Fecke W; Koukidou M; Farries TC; Harrison RA
    Transplant Proc; 1998 Aug; 30(5):2351-2. PubMed ID: 9723500
    [No Abstract]   [Full Text] [Related]  

  • 43. Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120.
    Bitton N; Verrier F; Debré P; Gorochov G
    Eur J Immunol; 1998 Dec; 28(12):4177-87. PubMed ID: 9862354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
    Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and characterization of a fragment containing the HIV-gp120 binding region of CD4 using a bovine papilloma virus (BPV) vector.
    Gidlund M; Sydow M; Stenbeck A; Flodby P; Fossum H; Matsuda S; Lundin K; Wigzell H; Lind P
    Arch Virol; 1990; 113(3-4):209-19. PubMed ID: 2171457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV therapeutic agents.
    Rausch DM; Hwang KM; Padgett M; Voltz AH; Rivas A; Engleman E; Gaston I; McGrath M; Fraser B; Kalyanaraman VS
    Ann N Y Acad Sci; 1990; 616():125-48. PubMed ID: 2078014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients.
    Spruth M; Stoiber H; Kacani L; Schönitzer D; Dierich MP
    AIDS Res Hum Retroviruses; 1999 Apr; 15(6):533-43. PubMed ID: 10221530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement.
    Marschang P; Sodroski J; Würzner R; Dierich MP
    Eur J Immunol; 1995 Jan; 25(1):285-90. PubMed ID: 7531147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Virolysis and in vitro neutralization of HIV-1 by humanized monoclonal antibody hNM-01.
    Nakamura M; Terada M; Sasaki H; Kamada M; Ohno T
    Hybridoma; 2000 Dec; 19(6):427-34. PubMed ID: 11152394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced HIV-1 neutralization by a CD4-VH3-IgG1 fusion protein.
    Meyuhas R; Noy H; Fishman S; Margalit A; Montefiori DC; Gross G
    Biochem Biophys Res Commun; 2009 Aug; 386(2):402-6. PubMed ID: 19538939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
    Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
    J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.
    Cavacini LA; Emes CL; Wisnewski AV; Power J; Lewis G; Montefiori D; Posner MR
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1271-80. PubMed ID: 9764911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG).
    Flasher D; Konopka K; Chamow SM; Dazin P; Ashkenazi A; Pretzer E; Düzgünes N
    Biochim Biophys Acta; 1994 Aug; 1194(1):185-96. PubMed ID: 8075135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.
    Perno CF; Baseler MW; Broder S; Yarchoan R
    J Exp Med; 1990 Apr; 171(4):1043-56. PubMed ID: 2324685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement.
    Eaton AM; Ugen KE; Weiner DB; Wildes T; Levy JA
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):13-8. PubMed ID: 7514015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.
    Shubin Z; Li W; Poonia B; Ferrari G; LaBranche C; Montefiori D; Zhu X; Pauza CD
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propagation of a mouse myeloma cell line J558L producing human CD4 immunoglobulin G1.
    Schlaeger EJ; Schumpp B
    J Immunol Methods; 1992 Jan; 146(1):111-20. PubMed ID: 1735775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.